PartnerCARE - A randomized controlled pilot study to test the feasibility and efficacy of a psycho-oncological online training for partners of patients with cancer

PartnerCARE - A randomized controlled pilot study to test the feasibility and efficacy of a psycho-oncological online training for partners of patients with cancer - PartnerCARE

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00017019

Enrollment

Registered

2019-04-08

Start date

2019-04-08

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No disease, because preventive. The extent of psychosocial stress of partners of patients with cancer is being investigated.

Interventions

Group 1: Training group: Participants (partners of patients with cancer) get access to the guided online training 'PartnerCARE' immediately after the first online survey. The training consists of six

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Partner of a person with cancer, access to the internet, written informt consent from participants

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
3 times of measurement (self-report with questionnaires): T0 (before randomisation), T1 (8 weeks post randomisation), T2 (16 weeks post randomisation) Feasibility as primary endpoint Process-related: recruitment (strategies and figures), questions due to satisfaction after each completed session Time of measurement: drop-out rate (T1, T2), acceptance (APOI (T0, T1, T2)), adverse events (INEP-On (T1, T2)), satisfaction (CSQ-I (T1, T2))	—

Measure

Time frame

3 times of measurement (self-report with questionnaires): T0 (before randomisation), T1 (8 weeks post randomisation), T2 (16 weeks post randomisation) Feasibility as primary endpoint Process-related: recruitment (strategies and figures), questions due to satisfaction after each completed session Time of measurement: drop-out rate (T1, T2), acceptance (APOI (T0, T1, T2)), adverse events (INEP-On (T1, T2)), satisfaction (CSQ-I (T1, T2))

—

Secondary

Measure	Time frame
3 times of measurement (self-report with questionnaires): T0 (before randomisation), T1 (8 weeks post randomisation), T2 (16 weeks post randomisation) Distress (distress thermometer (T0, T1, T2)), depression (PHQ-8 (T0, T1, T2)), anxiety (GAD-7 (T0, T1, T2)), quality of life (VR-12 (T0, T1, T2)), burden of family caregiver (BSFC-s (T0, T1, T2)), fear of progression (PA-F-P-KF (T0, T1, T2)), perceived social support (ESSI, (T0, T1, T2)), received social support (OSS-3 (T0, T1, T2)), loneliness (How lonely do you currently feel? (T0, T1, T2)), self-efficacy expectancy (SWE (T0, T1, T2)), coping (Brief COPE (T0, T1, T2))	—

Measure

Time frame

3 times of measurement (self-report with questionnaires): T0 (before randomisation), T1 (8 weeks post randomisation), T2 (16 weeks post randomisation) Distress (distress thermometer (T0, T1, T2)), depression (PHQ-8 (T0, T1, T2)), anxiety (GAD-7 (T0, T1, T2)), quality of life (VR-12 (T0, T1, T2)), burden of family caregiver (BSFC-s (T0, T1, T2)), fear of progression (PA-F-P-KF (T0, T1, T2)), perceived social support (ESSI, (T0, T1, T2)), received social support (OSS-3 (T0, T1, T2)), loneliness (How lonely do you currently feel? (T0, T1, T2)), self-efficacy expectancy (SWE (T0, T1, T2)), coping (Brief COPE (T0, T1, T2))

—

Countries

Austria, Germany, Switzerland

Contacts

Public ContactDaniela Bodschwinna

Klinik für psychosomatische Medizin und Psychotherapie, Universitätsklinikum Ulm

daniela.bodschwinna@uni-ulm.de0731 5032815

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 17, 2026